DOTA-CXCR4-L

DOTA-CXCR4-L
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T80216-5mg 5 mg

7 - 10 business days*

-
TGM-T80216-50mg 50 mg

7 - 10 business days*

-
 
Description: DOTA-CXCR4-L, a peptide targeting the CXCR4 receptor, is utilized in cancer... more
Product information "DOTA-CXCR4-L"
Description: DOTA-CXCR4-L, a peptide targeting the CXCR4 receptor, is utilized in cancer research, notably in the contexts of glioblastoma and triple-negative breast cancer [1]. Target: CXCR
Supplier: TargetMol
Supplier-Nr: T80216

Properties

Conjugate: No
MW: 1223.34 D
Formula: C58H78N16O14

Database Information

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "DOTA-CXCR4-L"
Write a review
or to review a product.
Viewed